Down-regulation of Toll-like receptor 4 in the granulation tissues of postoperative mastoid cavities with otorrhea

References

• Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci U S A 1998; 95: 588–93
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11: 443–51
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of Gram positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999; 163: 1–5
   PubMed Web of Science ®Google Scholar
• Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, Bassetti M, et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999; 401: 811–15
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-defcient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 2000; 165: 5392–6
   PubMed Web of Science ®Google Scholar
• Takeuchi O, Takeda K, Hoshino K, Adachi O, Ogawa T, Akira S. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int Immunol 2000; 12: 113–17
   PubMed Web of Science ®Google Scholar
• Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413: 78–83
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194–9
   PubMed Web of Science ®Google Scholar
• Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtos C, et al. Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 2002; 416: 750–6
   PubMed Web of Science ®Google Scholar
• Silverman N, Maniatis T. NF-κB signaling pathways in mammalian and insect innate immunity. Genes Dev 2001; 15: 2321–42
   PubMed Web of Science ®Google Scholar
• Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, et al. Induction of in vitro reprogramming by toll-like receptor (TLR) 2 and TLR4 agonists in murine macrophages: effects of TLR “homotolerance” versus “heterotolerance” on NF-kappa B signaling pathway components. J Immunol 2003; 170: 508–19
   PubMed Web of Science ®Google Scholar
• Muthukuru M, Jotwani R, Wutler C. Oral mucosal endotoxin tolerance induction in chronic periodontitis. Infect Immun 2005; 73: 687–94
   PubMed Web of Science ®Google Scholar
• Youngs R. The histopathology of mastoidectomy cavities, with particular reference to persistent disease leading to chronic otorrhea. Clin Otolaryngol 1992; 117: 505–10
   Google Scholar
• Youngs R. Temporal bone histopathology of open mastoidectomy cavities. J Laryngol Otol 1993; 1107: 569–73
   Google Scholar
• Pettigrew AM. Histopathology of the temporal bone after operative mastoid surgery. Clin Otolaryngol 1980; 5: 227–34
   PubMedGoogle Scholar
• Sakai Y, Yamasoba T, Ito K, Kaga K. Bacteriological study of pre- and postoperative culture in aural disease. Otol Jpn 2001; 11: 48–53
   Google Scholar
• Szczepan'ski M, Szyfter W, Jenek R, Wro'bel M, Lisewska IM, Zeromski J. Toll-like receptors 2, 3 and 4 (TLR-2, TLR-3 and TLR-4) are expressed in the microenvironment of human acquired cholesteatoma. Eur Arch Otorhinolaryngol 2006; 263: 603–7
   PubMedGoogle Scholar
• MacArthur CJ, Hefeneider SH, Kempton JB, Trune DR. C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope 2006; 116: 1071–9
   PubMed Web of Science ®Google Scholar
• Hatada EN, Krappmann D, Scheidereit C. NF-kappaB and the innate immune response. Curr Opin Immunol 2000; 12: 52–8
   PubMed Web of Science ®Google Scholar
• Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface Toll-like receptor 4 expression. J Immunol 2000; 164: 3476–9
   PubMed Web of Science ®Google Scholar
• Akira S. Toll-like receptors and innate immunity. Adv Immunol 2001; 78: 1–56
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Hernandez LD, Galan JE, Janeway C, Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 2002; 110: 191–202
   PubMed Web of Science ®Google Scholar
• Nakayama K, Okugawa S, Yanagimoto S, Kitazawa T. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J Biol Chem 2004; 279: 6629–34
   PubMedGoogle Scholar
• Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different Toll-like receptors independent of paracrine mediators. J Immunol 2001; 166: 5161–7
   PubMed Web of Science ®Google Scholar